ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Recognition of ear, nose and throat involvement in patients with ANCA-associated vasculitis: from in-depth interviews to insights for the future.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEar, nose, and throat (ENT) manifestations are common in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Although timely intervention is crucial, diagnosis and treatment are often delayed due to its rarity and nonspecific symptoms. Currently, no standardized tool exists to assess AAV activity in the ENT region. This study aims to determine key indicators of active AAV in the ENT region, thereby supporting the development of a systematic examination method.
methodsA qualitative exploratory multicentre study was conducted. In-depth interviews with four otorhinolaryngologists were thematically analysed. Identified ENT symptoms and rhinoscopic findings associated with AAV were compiled, and statements regarding diagnosis and management were formulated. These items then formed the basis of an online survey presented to Dutch otorhinolaryngologists. Respondents rated items on a 0-10 agreement scale.
resultsOf 29 initiated surveys, 25 (86.2%) were completed. Highest-rated symptoms supporting active AAV included nasal crusting (9.7/10), systemic symptoms (7.5/10), no effect of conventional therapy for chronic rhinosinusitis (7.6/10) and epistaxis (7.5/10). Most suspect rhinoscopic findings were nasal crusting (9.3/10), mucosal haemorrhaging (8.8/10) and septal perforation (8.6/10). Respondents strongly agreed that ENT involvement should be monitored by an otorhinolaryngologist (8.3/10), nasal lavage should precede rhinoscopy (7.6/10) and thorough nasal hygiene instructions should be provided (9.1/10).
conclusionKey indicators of AAV activity include nasal crusting, lack of response to conventional treatment, systemic symptoms, nasal crusting, mucosal haemorrhaging and septal perforation. These data may facilitate the establishment of a standardized scoring system to optimize diagnostic accuracy and disease monitoring.
Indexed as
Identifiers
42562907What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.